U.S. market Closed. Opens in 11 hours 52 minutes

MBRX | Moleculin Biotech, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue127.00K222.00K260.00K285.00K185.00KN/AN/AN/A
Gross Profit-127.00K-222.00K-260.00K-285.00K-185.00KN/AN/AN/A
Operating Expenses29.50M30.64M22.97M19.74M17.52M15.03M8.65M3.88M
Selling, General & Admin10.02M11.67M8.39M6.79M6.31M5.30M4.09M2.38M
Research & Development19.49M18.97M14.42M12.76M11.01M9.73M4.54M1.50M
Other Operating Expenses127.00K40.00K164.00K200.00K199.00K-40.00K18.00K6.16K
Operating Income-29.63M-30.64M-22.97M-19.74M-17.52M-15.03M-8.65M-3.88M
Other Expenses / Income-138.00K1.61M7.07M2.39M4.09M3.15M-1.15M-43.21K
Before Tax Income-29.77M-29.02M-15.89M-17.36M-13.43M-11.88M-9.80M-3.93M
Income Tax ExpensesN/A-1.61M-7.03M-2.36M-229.00K3.15MN/AN/A
Net Income-29.77M-27.41M-8.86M-15.00M-13.21M-11.88M-9.80M-3.93M
Interest ExpensesN/A-1.61MN/AN/AN/AN/AN/A43.21K
Basic Shares Outstanding1.98M1.91M1.79M656.38K452.46K4.32M3.09M1.64M
Diluted Shares Outstanding1.98M1.91M1.79M656.38K452.46K4.32M3.09M1.64M
EBITDA-29.50M-31.98M-29.53M-21.89M-21.39M-18.21M-9.79M-3.88M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-29.77M-30.64M-15.89M-17.36M-13.43M-8.73M-9.80M-3.88M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙